Allergan embraces growth pharma model, accelerates business with the Microsoft Secure Productive Enterprise

 

With 22 acquisitions in the past five years, it’s easy to see how Allergan is a leading exponent of the new “Growth Pharma” business model. Expanding its diversified portfolio of branded and generic pharmaceuticals by acquiring companies like Botox and Zeltiq Aesthetics, Allergan is pursuing a rigorous growth strategy, rather than investing heavily in R&D. This approach, known in the industry as “open science,” sees the company enriching its intellectual property by acquiring new talent, promising new products and partnering closely with many external stakeholders. It requires an agile, IT-enabled workplace to pull off the rapid employee onboarding and a rich culture of teamwork and creativity to make this strategy work. At the same time, it’s critically important for Allergan to ensure the security of its IP and to remain compliant in this highly regulated industry. So, it’s great news that Allergan chose the Secure Productive Enterprise solution to enable this disruptive way of doing business in the pharmaceutical industry.

Read the full post on the Office Blog